These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 2975459)

  • 1. Myocardial effect of converting enzyme inhibition in hypertensive and normotensive rats.
    Michel JB; Salzmann JL; Cerol ML; Dussaule JC; Azizi M; Corman B; Camilleri JP; Corvol P
    Am J Med; 1988 Mar; 84(3A):12-21. PubMed ID: 2975459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure.
    Michel JB
    Eur Heart J; 1990 May; 11 Suppl D():17-26. PubMed ID: 2141818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme (ACE) inhibitors in experimental hypertension: influence on heart and arteries.
    Levy BI; Salzmann JL; Devissaguet M; Safar ME; Michel JB
    Basic Res Cardiol; 1991; 86 Suppl 1():43-53. PubMed ID: 1827984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction.
    Michel JB; Lattion AL; Salzmann JL; Cerol ML; Philippe M; Camilleri JP; Corvol P
    Circ Res; 1988 Apr; 62(4):641-50. PubMed ID: 2964944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
    Brilla CG; Matsubara L; Weber KT
    Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antihypertensive treatment on the left ventricular isomyosin profile in one-clip, two kidney hypertensive rats.
    Dussaule JC; Michel JB; Auzan C; Schwartz K; Corvol P; Menard J
    J Pharmacol Exp Ther; 1986 Feb; 236(2):512-8. PubMed ID: 2935625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes and cyclic GMP content of the aorta after calcium antagonism or angiotensin converting enzyme inhibition in renovascular hypertensive rats.
    Véniant M; Gray GA; Heudes D; Ménard J; Clozel JP
    J Hypertens; 1995 Jul; 13(7):731-7. PubMed ID: 7594436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
    Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
    Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of heart and arteries by chronic converting enzyme inhibition in spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Devissaguet M; Safar ME
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):240S-245S. PubMed ID: 1828353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Safar M; Camilleri JP
    Circ Res; 1988 Jul; 63(1):227-39. PubMed ID: 3383377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy.
    Tanaka K; Honda M; Kuramochi T; Hashimoto M; Masumura S; Mansoor AM; Ishikawa S; Morioka S
    J Hypertens; 1994 Oct; 12(10):1147-54. PubMed ID: 7836730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats.
    Frohlich ED; Sasaki O
    J Am Coll Cardiol; 1990 Nov; 16(6):1492-9. PubMed ID: 2229803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
    Brilla CG; Janicki JS; Weber KT
    Circulation; 1991 May; 83(5):1771-9. PubMed ID: 1850668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia.
    Amrani FC; Cheaw SL; Chevalier B; Paolaggi F; Jouquey S; Hamon G; Swynghedauw B
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):155-65. PubMed ID: 7511729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular myosin pattern of spontaneously hypertensive turkeys is unaffected by labetalol treatment.
    Pauletto P; Vescovo G; Scannapieco G; Angelini A; Dalla Libera L; Carraro U; Tessari F; Dal Palù C
    Basic Res Cardiol; 1988; 83(3):277-85. PubMed ID: 2970841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats.
    Pu Q; Schiffrin EL
    Am J Hypertens; 2001 Oct; 14(10):1067-72. PubMed ID: 11710787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.